Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives

Viracta Therapeutics

26/12/2024 21:58

Dec 26 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS ANNOUNCES CLOSURE OF NAVAL-1 CLINICAL
TRIAL
AND EXPLORATION OF STRATEGIC ALTERNATIVES
    * VIRACTA THERAPEUTICS INC - TO CLOSE PHASE 2 CLINICAL TRIAL
OF
NANA-VAL
    * VIRACTA THERAPEUTICS INC - CLOSURE OF TRIAL NOT DUE TO NEW
SAFETY FINDING
    * VIRACTA THERAPEUTICS INC - POTENTIAL ALTERNATIVES INCLUDE
MERGER, LICENSING AGREEMENT, SALE

Source text:  ID:nGNXbcqMCQ 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))